McKesson to Buy Emendo - Analyst Blog
November 07 2012 - 11:40AM
Zacks
McKesson Corporation (MCK) recently announced
that it has inked a deal with Emendo Ltd. to acquire the latter.
Emendo has developed CapPlan, which is utilized in more than 40
hospitals across New Zealand, Australia, Canada and the UK to
optimize operational efficiency by forecasting patient demand and
plan resourcing.
CapPlan is a system which forecasts workloads covering long-term
and short-term trends. It helps hospitals to allocate resources
efficiently and recognize unnecessary costs. CapPlan uses clinician
schedules, workloads, patient flow, length of stay and discharges
in its forecasting process. The company stated that a 400-bed
hospital using CapPlan has saved $895,000 for inpatient areas. We
believe the acquisition of Emendo will complement McKesson’s
technology solutions segment.
The company has been pursuing acquisitions regularly to supplement
organic growth. Last month, McKesson entered into an agreement to
buy PSS World Medical, Inc. (PSSI) for $29.00 per
share in cash. The total value of the deal, in which McKesson will
assume PSS World Medical’s debt, is estimated to be approximately
$2.1 billion.
McKesson expects to generate more than $100 million in annual
savings (pre-tax) by the fourth year after the closure of the deal.
On the second quarter 2013 conference call, the company stated that
the deal is expected to add earnings of 15 to 25 cents per share
after a year of closing.
The company also announced that it will purchase Med3000, a health
care management and technology service company. The deal, expected
to be completed in the next few months, should boost the medical
billing and practice management services of revenue management
solutions at McKesson apart from facilitating its expansion into
high potential markets.
Neutral on McKesson
We currently have a Neutral recommendation on McKesson. The stock
carries a Zacks #3 Rank (Hold rating) in the short run.
We are encouraged by the company’s acquisition strategy for
expansion but the competition in the pharmaceutical distribution
market remains tough, which includes players like
AmerisourceBergen Corporation’s (ABC).
AMERISOURCEBRGN (ABC): Free Stock Analysis Report
MCKESSON CORP (MCK): Free Stock Analysis Report
PSS WORLD MED (PSSI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Jun 2024 to Jul 2024
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Jul 2023 to Jul 2024